Using Syndromic Surveillance to Rapidly Describe the Early Epidemiology of Flakka Use in Florida, June 2014 – August 2015


Syndromic surveillance has historically been used to track infectious disease, but in recent years, many jurisdictions have utilized the systems to conduct all hazards surveillance and provide situational awareness with respect to previously identified issues. Flakka is a synthetic drug (class: cathinones) that recently has been featured in the media. Flakka is a stimulant that causes delusions, aggression, erratic behavior, a racing heart and sometimes death. Two specific counties (one in Florida and one in Kentucky) have been at the center of this emerging epidemic. In August 2015, Florida Department of Health (FDOH) partner agencies requested flakka-related health data in an effort to better understand the epidemiology and context of this problem. ESSENCE-FL is a large syndromic surveillance system, with four main data sources, that captures 87% of all emergency department (ED) visits statewide.


To characterize flakka usage in Florida using multiple data sources within the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE-FL)


Primary Topic Areas: 
Original Publication Year: 
Event/Publication Date: 
December, 2015

September 25, 2017

Contact Us

NSSP Community of Practice



This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications